Low-income group psilocybin assisted therapy for depression: An Oregon feasibility study

This open-label, uncontrolled feasibility study (n=19) found that group psilocybin therapy was practical for low-income adults with depression, with participants reporting improved depression and quality-of-life measures after treatment. No severe adverse events were reported, and satisfaction was high, but the study had no comparison group.